Disc Medicine, Inc.
IRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $96,671 | $69,264 | $33,437 | $25,170 |
| G&A Expenses | $33,049 | $21,861 | $14,038 | $5,763 |
| SG&A Expenses | $33,049 | $21,861 | $14,038 | $5,763 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $129,720 | $91,125 | $47,475 | $30,933 |
| Operating Income | -$129,720 | -$91,125 | -$47,475 | -$30,933 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $20,718 | $14,795 | $648 | -$5,036 |
| Pre-Tax Income | -$109,002 | -$76,330 | -$46,827 | -$35,969 |
| Tax Expense | $355 | $99 | $0 | $0 |
| Net Income | -$109,357 | -$76,429 | -$46,827 | -$35,969 |
| % Margin | – | – | – | – |
| EPS | -3.96 | -3.42 | -45.05 | -44.88 |
| % Growth | -15.8% | 92.4% | -0.4% | – |
| EPS Diluted | -3.96 | -3.42 | -45.05 | -44.88 |
| Weighted Avg Shares Out | 27,606 | 22,316 | 1,039 | 801 |
| Weighted Avg Shares Out Dil | 27,606 | 22,316 | 1,039 | 801 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21,292 | $14,797 | $709 | $14 |
| Interest Expense | $572 | $0 | $0 | $2,158 |
| Depreciation & Amortization | $156 | $100 | $89 | $32 |
| EBITDA | -$108,274 | -$76,230 | -$47,386 | -$30,901 |
| % Margin | – | – | – | – |